APA (7th ed.) Citation

Rom, J., Marmé, F., Schütz, F., Sohn, C., Schneeweiss, A., Bechstein, S., . . . Wallwiener, M. (2014). Efficacy and toxicity profile of pegylated liposomal doxorubicin (Caelyx) in patients with advanced breast cancer. Anti-cancer drugs, 25(2), . https://doi.org/10.1097/CAD.0000000000000037

Chicago Style (17th ed.) Citation

Rom, Joachim, et al. "Efficacy and Toxicity Profile of Pegylated Liposomal Doxorubicin (Caelyx) in Patients with Advanced Breast Cancer." Anti-cancer Drugs 25, no. 2 (2014). https://doi.org/10.1097/CAD.0000000000000037.

MLA (9th ed.) Citation

Rom, Joachim, et al. "Efficacy and Toxicity Profile of Pegylated Liposomal Doxorubicin (Caelyx) in Patients with Advanced Breast Cancer." Anti-cancer Drugs, vol. 25, no. 2, 2014, https://doi.org/10.1097/CAD.0000000000000037.